Feliselin

Feliselin is a medication containing Selegiline Hydrochloride, used for various therapeutic purposes. This oral medication is manufactured by Rafarm Sa. and is available in the EU market.

Feliselin, containing Selegiline Hydrochloride, is primarily used for its therapeutic effects in managing certain conditions. It is often prescribed for its ability to support cognitive function and may be used in the treatment of Parkinson's disease. The medication works by affecting certain chemicals in the brain, which can help improve symptoms associated with these conditions.

Common effects of Feliselin may include improvements in cognitive function and motor skills. Some users may experience enhanced mood and energy levels. However, individual responses can vary, and it is important to consult with a healthcare provider to understand potential effects.

Feliselin should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Avoid sudden discontinuation of the medication without medical advice.

Feliselin may interact with certain substances, including alcohol and other medications that affect brain chemicals. It is advisable to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.